Incidence of Cholangitis in Post‐Endoscopic Retrograde Cholangiopancreatography ( ERCP ): A Systematic Review and Meta‐Analysis
JGH Open · 2026-03 · 10 (3)
DOI: 10.1002/jgh3.70359 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JGH Open, online erschienen am 13.03.2026. Verfasst von Shiwen Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection Control Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai China. Die Arbeit nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Endoscopic retrograde cholangiopancreatography (ERCP) is a procedure that combines x‐ray and upper gastrointestinal (GI) endoscopy for diagnosis and treatment of pancreatic and biliary diseases. Cholangitis is the main infectious complication after ERCP surgery. Current evidence synthesis remains limited by the absence of cholangitis‐specific incidence quantification in prior meta‐analyses, which predominantly report composite infection metrics. This important evidence gap impedes accurate risk assessment for this procedure‐dominant complication. To address this deficit, we conducted a systematic review and meta‐analysis to determine the isolated incidence of post‐ERCP cholangitis.
Methods
We conducted a systematic review and a meta‐analysis of the incidence of cholangitis in Post‐ERCP for studies that were published in both PubMed and EMBASE up to February 6th, 2023. Overall and subgroup pooled effect estimates (continents, age, and publication year) with 95% confidence interval were evaluated by using inverse‐variance pooling and logit‐transformed proportions model. Risk of bias assessment was accessed by using ROBINS‐I guidelines.
Results
Our search initially retrieved 1622 unique studies, of which 97 studies met the inclusion criteria. Overall pooled rate was 1.70% (95% CI: 1.41%–2.04%). The subgroup continent pooled rate for South America, North America, Europe, Asia, and Africa were 1.04% (95% CI: 0.22%–4.89%, n = 2 studies), 1.21% (95% CI: 0.75%–1.93%, n = 17 studies), 1.79% (95% CI: 1.36%–2.35%, n = 34 studies), 1.86% (95% CI: 1.41%–2.45%, n = 41 studies), 2.35% (95% CI: 0.01%–83.49%, n = 3 studies), respectively.
Conclusion
We provide robust point effect estimates of post‐ERCP cholangitis. Given the mortality and morbidity burden associated with ERCP‐related infectious outbreaks, this finding can inform public health policy regarding the health effects of hospital‐related infection on taking appropriate measures, especially in vulnerable populations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infection Control Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai China.
- Department of Biliary-Pancreatic Surgery Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai China.
- Department of Epidemiology Harvard T.H. Chan School of Public Health Boston Massachusetts USA.
ORCID-Profile: Haiqun Ban
Zitieren
APA
Huang, S., Huang, Y., Lu, F., Yang, Y., Yang, L., Papatheodorou, S., & Ban, H. (2026). Incidence of Cholangitis in Post‐Endoscopic Retrograde Cholangiopancreatography ( ERCP ): A Systematic Review and Meta‐Analysis. JGH Open, 10(3). https://doi.org/10.1002/jgh3.70359
Vancouver
Huang S, Huang Y, Lu F, Yang Y, Yang L, Papatheodorou S, et al. Incidence of Cholangitis in Post‐Endoscopic Retrograde Cholangiopancreatography ( ERCP ): A Systematic Review and Meta‐Analysis. JGH Open. 2026;10(3). doi:10.1002/jgh3.70359
BibTeX
@article{Huang2026,
author = {Huang, Shiwen and Huang, Ying and Lu, Feng and Yang, Ya and Yang, Linhua and Papatheodorou, Stefania and Ban, Haiqun},
title = {Incidence of Cholangitis in Post‐Endoscopic Retrograde Cholangiopancreatography ( ERCP ): A Systematic Review and Meta‐Analysis},
journal = {JGH Open},
year = {2026},
volume = {10},
number = {3},
doi = {10.1002/jgh3.70359}
}
EUVIMED